Podcasts by 301 Moved Permanently
The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.
Further podcasts by ACT ToxChats
Podcast on the topic Wissenschaft
All episodes
Off the Beaten Path: The Nonclinical Development of Gene Therapy Products to Cure Monogenic Diseases from 2022-03-24T16:30:02
The idea behind gene therapy is to introduce, remove, or change a portion of person’s genetic code in order to cure a disease. Several gene therapy products are currently under development and ther...
Listen
Digital Pathology from 2022-01-20T21:30:03
In this episode of ToxChats, Dr. Daniel Rudmann, an ACVP board-certified investigative and toxicologic pathologist and translational medicine scientist with over 20 years of experience in drug disc...
Listen
Expedited FDA Programs from 2021-06-17T15:45:12
The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the s...
Listen
Toxicology Salary Survey from 2021-05-13T18:00:12
The toxicology salary survey began in 1988 to provide the profession with accurate salary information. Since then, the survey has continued to collect information on toxicology salary and employmen...
Listen
Pediatric Drug Development from 2021-03-04T15:00:09
Drug development targeted at pediatric populations has been the subject of a great deal of careful thought and effort by clinical and nonclinical scientists and regulators over the past 25 years. I...
Listen
CAR/T: New Modalities Paving the Way for Cancer from 2021-01-06T17:28:53
(CAR)T cells, also known as chimeric antigen receptor T cells, have transformed the landscape of cancer treatment. Instead of a standard chemotherapy, CAR-T treatment involves taking a patient's bl...
Listen
History and Risk Assessment of Vaccines—Q&A from 2020-11-05T15:00:18
Drs. Lisa Plitnick and Alan Stokes recently presented an ACT Signature Webinar titled “History and Risk Assessment of Vaccines: A Practical Perspective from an Immunologist and a Toxicologist.” In ...
Listen
Scientific Communication: Distilling and Rehearsing to Reach Your Audience from 2020-08-20T20:26:45
In this episode, Dr. Nicholas Ponzio, master educator and professor of pathology, immunology, and laboratory medicine at Rutgers University's New Jersey Medical School and School of Graduate Studie...
Listen
AI and Big Data for Safety Testing from 2020-04-27T13:00:01
Dr. Thomas Hartung, is a professor at Johns Hopkins University and Director of the Center for Alternatives to Animal Testing. Dr. Hartung discusses some of his innovative contributions to the field...
Listen
Shining a Light on the Science and Strategy of Phototoxicity Assessments from 2020-04-10T18:05:22
In this episode, Dr. Doug Learn, Director of Toxicology at Charles River Safety Assessment in Horsham, Pennsylvania, was interviewed. Dr. Learn is considered an expert in the field of phototoxicity...
Listen
The Twists and Turns of GI Health and Medicine: An Interview with Dr. Alessio Fasano from 2020-02-10T14:00:04
In this interview, during the ACT 40th anniversary Annual Meeting in Phoenix, Arizona, plenary speaker Dr. Alessio Fasano highlights the exciting advancements and future outlooks of gastrointestina...
Listen
The Scientific Approach to Address Uncommon Routes and Best Practices for Forming a Working Group from 2019-10-03T14:26:21
In this episode, Dr. Armaghan Emami, a toxicologist with the Center for Drug Evaluation and Research at the US FDA and 2019 award winner of Best Paper Published in International Journal of Toxicolo...
Listen
CRISPR Then and Now: An Interview with Dr. Jacob Corn, ACT 2015 Plenary Speaker from 2019-08-16T14:00:13
Dr. Jacob Corn, ACT’s 2015 Plenary Lecturer, is a Professor of Genome Biology at the Swiss Federal Institute of Technology in Zurich. The Corn Laboratory develops next-generation genome editing an...
Listen
In Vitro and Alternative Models for Regulatory Submission from 2018-11-30T14:03:29
In this two-chapter episode, in vitro and alternative models for regulatory submissions were explored from both an industry and government perspective. In the first chapter, Dr. Clive Roper, the he...
Listen
Regulation of E-Cigarettes from 2018-07-19T07:00
In this episode, Dr. Arianne Motter, a toxicologist with the Center for Drug Evaluation and Research at the US Food and Drug Administration, discusses the complex regulation of e-cigarettes at the ...
Listen
The Opioid Epidemic from 2018-04-26T15:57
In this episode of ToxChats, the opioid epidemic was discussed from a preclinical drug development perspective with Dr. Carrie Blum, Associate Director, Toxicology at Sunovion Pharmaceuticals and D...
Listen
Biomarkers from 2017-09-27T19:51
The role of biomarkers and their qualification in nonclinical and clinical development is discussed with Dr. William Mattes. Dr. Mattes is Director of the Division of Systems Biology, part of the F...
Listen
Microbiome from 2017-06-27T19:50
Dr. Rodney Dietert has authored a number of books on the immune system and extensively published on the topics of noncommunicable diseases, immune dysfunction, and the microbiome. His latest book i...
Listen
Oligonucleotide Therapeutics from 2017-05-05T19:48
Oligonucleotide therapeutics are all medications that utilize RNA- or DNA-based techniques as the effective entity. The nonclinical development of these therapeutics presents unique challenges and ...
Listen